This research, despite limitations of a small sample size and limited follow-up time, contributes valuable insights into understanding and predicting the success of BS, highlighting the potential role of FSTL1 as a useful biomarker in obesity. Here, FSTL1 is linked to obesity due to melanocortin 4 receptor deficiency.